ProShares Ultra Nasdaq Biotechnology (BIB) Holdings
BIB holdings summary
as of Oct 25, 2026- Holdings
- 246 positions listed
- Top 10 weight
- 46.2% of net assets
- Effective holdings
- 14 equal-weight equivalent
- Largest holding
- IQMM 18.43% Proshares Genius Money Market ETF
- Annual turnover
- 23.2% of the portfolio traded
Top 1046.2%
Top 2558.3%
Top 5067.5%
Top 10075.0%
All BIB holdings
245 holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | IQMM | Proshares Genius Money Market ETF | Other | 18.43% | $17.5M | — | — |
| 2 | GILD | Gilead Sciences, Inc. | Healthcare | 5.17% | $4.9M | $193.67B | — |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 5.05% | $4.8M | $126.66B | 28.9 |
| 4 | AMGN | Amgen Inc. | Healthcare | 4.91% | $4.7M | $233.82B | 26.9 |
| 5 | MRNA | Moderna, Inc. | Healthcare | 3.35% | $3.2M | $87.04B | — |
| 6 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 3.25% | $3.1M | $81.41B | 19.6 |
| 7 | RVMD | Revolution Medicines, Inc. | Healthcare | 1.64% | $1.6M | $38.14B | — |
| 8 | ILMN | Illumina, Inc. | Healthcare | 1.62% | $1.5M | $39.64B | 49.0 |
| 9 | BIIB | Biogen Inc. | Healthcare | 1.55% | $1.5M | $34.37B | 41.3 |
| 10 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 1.22% | $1.2M | $31.02B | 39.1 |
| 11 | RPRX | Royalty Pharma plc | Healthcare | 1.10% | $1.0M | $35.22B | 32.4 |
| 12 | ROIV | Roivant Sciences Ltd. | Healthcare | 1.08% | $1.0M | $24.22B | — |
| 13 | UTHR | United Therapeutics Corporation | Healthcare | 1.02% | $971,959.27 | $22.87B | 19.1 |
| 14 | INCY | Incyte Corporation | Healthcare | 0.97% | $920,658.79 | $22.92B | 14.4 |
| 15 | ARGX | argenx SE | Healthcare | 0.94% | $886,616.51 | $51.51B | 31.2 |
| 16 | GH | Guardant Health, Inc. | Healthcare | 0.90% | $853,427.66 | $21.28B | — |
| 17 | INSM | Insmed Incorporated | Healthcare | 0.85% | $801,747.87 | $21.02B | — |
| 18 | VTRS | Viatris Inc. | Healthcare | 0.84% | $798,144.51 | $21.43B | — |
| 19 | MEDP | Medpace Holdings, Inc. | Healthcare | 0.75% | $710,431.11 | $17.26B | 36.3 |
| 20 | EXEL | Exelixis, Inc. | Healthcare | 0.64% | $608,588.74 | $15.42B | 19.6 |
| 21 | ASND | Ascendis Pharma A/S | Healthcare | 0.62% | $585,925.50 | $14.82B | 17.3 |
| 22 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 0.61% | $576,158.49 | $13.79B | 19.9 |
| 23 | HALO | Halozyme Therapeutics, Inc. | Healthcare | 0.59% | $562,977.78 | $13.83B | 35.6 |
| 24 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 0.58% | $546,762.65 | $12.98B | — |
| 25 | ONC | BeiGene, Ltd. | Healthcare | 0.57% | $544,676.49 | $41.99B | 66.0 |
| 26 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | 0.56% | $533,202.63 | $13.65B | 14.4 |
| 27 | SMMT | Summit Therapeutics Inc. | Healthcare | 0.52% | $489,014.05 | $11.67B | — |
| 28 | TEM | Tempus AI, Inc. | Healthcare | 0.45% | $429,179.29 | $11.68B | — |
| 29 | MDGL | Madrigal Pharmaceuticals, Inc. | Healthcare | 0.44% | $418,558.85 | $10.39B | — |
| 30 | BNTX | BioNTech SE | Healthcare | 0.44% | $413,058.99 | $22.03B | — |
| 31 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 0.42% | $402,628.20 | $10.58B | 147.8 |
| 32 | PCVX | Vaxcyte, Inc. | Healthcare | 0.39% | $374,275.44 | $10.01B | — |
| 33 | KYMR | Kymera Therapeutics, Inc. | Healthcare | 0.39% | $366,120.46 | $8.62B | — |
| 34 | TWST | Twist Bioscience Corporation | Healthcare | 0.38% | $360,525.77 | $8.80B | — |
| 35 | CAI | Caris Life Sciences, Inc. | Healthcare | 0.38% | $359,577.52 | $8.64B | 18.1 |
| 36 | KRYS | Krystal Biotech, Inc. | Healthcare | 0.38% | $357,775.84 | $9.37B | 39.7 |
| 37 | PTGX | Protagonist Therapeutics, Inc. | Healthcare | 0.37% | $349,241.56 | $8.33B | 125.0 |
| 38 | CYTK | Cytokinetics, Incorporated | Healthcare | 0.37% | $348,103.66 | $8.61B | — |
| 39 | SNY | Sanofi | Healthcare | 0.37% | $346,207.15 | $97.31B | 21.4 |
| 40 | TXG | 10x Genomics, Inc. | Healthcare | 0.34% | $326,104.19 | $9.10B | — |
| 41 | SYRE | Spyre Therapeutics, Inc. | Healthcare | 0.34% | $324,776.64 | $7.47B | — |
| 42 | NK | NantKwest Inc | Healthcare | 0.34% | $324,397.33 | — | — |
| 43 | AXSM | Axsome Therapeutics, Inc. | Healthcare | 0.32% | $305,147.80 | $8.23B | — |
| 44 | ARWR | Arrowhead Pharmaceuticals, Inc. | Healthcare | 0.32% | $304,294.37 | $7.90B | — |
| 45 | ALKS | Alkermes plc | Healthcare | 0.31% | $298,510.03 | $6.92B | 108.5 |
| 46 | IONS | Ionis Pharmaceuticals, Inc. | Healthcare | 0.30% | $283,053.51 | $7.14B | — |
| 47 | PRAX | Praxis Precision Medicines, Inc. | Healthcare | 0.30% | $281,915.60 | $6.75B | — |
| 48 | AMRX | Amneal Pharmaceuticals, Inc. | Healthcare | 0.29% | $271,864.12 | $6.68B | 39.1 |
| 49 | IOVA | Iovance Biotherapeutics, Inc. | Healthcare | 0.26% | $248,062.97 | $6.17B | — |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | Healthcare | 0.26% | $246,640.59 | $5.89B | 31.1 |
| 51 | RYTM | Rhythm Pharmaceuticals, Inc. | Healthcare | 0.25% | $240,476.95 | $5.91B | — |
| 52 | IMVT | Immunovant, Inc. | Healthcare | 0.25% | $239,149.39 | $5.52B | — |
| 53 | GRAL | GRAIL, Inc. | Healthcare | 0.23% | $219,236.08 | $5.26B | — |
| 54 | PTCT | PTC Therapeutics, Inc. | Healthcare | 0.22% | $208,994.95 | $4.94B | — |
| 55 | COGT | Cogent Biosciences, Inc. | Healthcare | 0.22% | $208,805.30 | $5.12B | — |
| 56 | CGON | CG Oncology, Inc. | Healthcare | 0.21% | $203,020.96 | $5.31B | — |
| 57 | MIRM | Mirum Pharmaceuticals, Inc. | Healthcare | 0.21% | $201,314.10 | $5.20B | — |
| 58 | KOD | Kodiak Sciences Inc. | Healthcare | 0.21% | $201,124.45 | $5.39B | — |
| 59 | ORKA | Oruka Therapeutics, Inc. | Healthcare | 0.21% | $200,555.50 | $4.76B | — |
| 60 | AAVXF | ABIVAX Société Anonyme | Healthcare | 0.20% | $190,409.19 | — | — |
| 61 | SRRK | Scholar Rock Holding Corporation | Healthcare | 0.20% | $189,555.76 | $4.86B | — |
| 62 | TVTX | Travere Therapeutics, Inc. | Healthcare | 0.19% | $183,961.07 | $4.61B | — |
| 63 | DFTX | Definium Therapeutics, Inc. | Healthcare | 0.19% | $182,917.99 | $4.31B | — |
| 64 | CRSP | CRISPR Therapeutics AG | Healthcare | 0.19% | $182,728.34 | $4.76B | — |
| 65 | ERAS | Erasca, Inc. | Healthcare | 0.19% | $182,349.04 | $4.68B | — |
| 66 | EWTX | Edgewise Therapeutics, Inc. | Healthcare | 0.18% | $173,814.77 | $4.04B | — |
| 67 | BCTG | BCTG Acquisition Corp | Financial Services | 0.18% | $173,435.46 | — | — |
| 68 | ARQT | Arcutis Biotherapeutics, Inc. | Healthcare | 0.17% | $159,875.45 | $3.62B | 131.0 |
| 69 | INDV | Indivior PLC | Healthcare | 0.16% | $156,272.09 | $3.83B | 11.6 |
| 70 | RLAY | Relay Therapeutics, Inc. | Healthcare | 0.16% | $149,444.66 | $3.57B | — |
| 71 | KNSA | Kiniksa Pharmaceuticals, Ltd. | Healthcare | 0.16% | $149,444.66 | $6.13B | 79.4 |
| 72 | VCYT | Veracyte, Inc. | Healthcare | 0.15% | $142,996.54 | $3.47B | 30.8 |
| 73 | ADPT | Adaptive Biotechnologies Corporation | Healthcare | 0.15% | $142,712.07 | $3.83B | — |
| 74 | ABCL | AbCellera Biologics Inc. | Healthcare | 0.15% | $142,332.77 | $3.82B | — |
| 75 | GMAB | Genmab A/S | Healthcare | 0.15% | $142,048.29 | $22.75B | 29.1 |
| 76 | AMLX | Amylyx Pharmaceuticals, Inc. | Healthcare | 0.14% | $135,410.52 | $3.31B | — |
| 77 | IDYA | IDEAYA Biosciences, Inc. | Healthcare | 0.14% | $130,764.08 | $3.17B | — |
| 78 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 0.14% | $130,669.26 | $3.24B | — |
| 79 | ACAD | ACADIA Pharmaceuticals Inc. | Healthcare | 0.14% | $128,393.45 | $3.29B | 8.6 |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | Healthcare | 0.13% | $121,755.68 | $3.19B | — |
| 81 | DYN | Dyne Therapeutics, Inc. | Healthcare | 0.12% | $118,247.14 | $2.66B | — |
| 82 | ELVN | Enliven Therapeutics, Inc. | Healthcare | 0.12% | $115,307.56 | $2.73B | — |
| 83 | DNLI | Denali Therapeutics Inc. | Healthcare | 0.12% | $112,747.28 | $2.81B | — |
| 84 | IRON | Disc Medicine, Inc. | Healthcare | 0.11% | $105,256.08 | $2.18B | — |
| 85 | NRIX | Nurix Therapeutics, Inc. | Healthcare | 0.11% | $105,161.25 | $2.67B | 10.0 |
| 86 | KH6_old | KINGHERO | Other | 0.10% | $96,152.85 | — | — |
| 87 | BEAM | Beam Therapeutics Inc. | Healthcare | 0.10% | $95,773.55 | $2.42B | — |
| 88 | MBX | MBX Biosciences, Inc. | Healthcare | 0.10% | $94,635.64 | $2.39B | — |
| 89 | ADMA | ADMA Biologics, Inc. | Healthcare | 0.10% | $92,739.14 | $2.39B | 15.3 |
| 90 | SUPN | Supernus Pharmaceuticals, Inc. | Healthcare | 0.10% | $92,454.66 | $2.21B | — |
| 91 | AUP | Aurinia Pharmaceuticals Inc | Technology | 0.09% | $89,989.20 | — | — |
| 92 | PGEN | Precigen, Inc. | Healthcare | 0.09% | $89,325.43 | $2.28B | — |
| 93 | AGIO | Agios Pharmaceuticals, Inc. | Healthcare | 0.09% | $87,903.05 | $1.87B | — |
| 94 | FTRE | Fortrea Holdings Inc. | Healthcare | 0.09% | $87,808.22 | $2.14B | — |
| 95 | PHVS | Pharvaris N.V. | Healthcare | 0.09% | $85,627.24 | $1.95B | — |
| 96 | VCEL | Vericel Corporation | Healthcare | 0.09% | $85,437.59 | $2.05B | 85.4 |
| 97 | HRMY | Harmony Biosciences Holdings, Inc. | Healthcare | 0.09% | $84,299.69 | $2.21B | 12.2 |
| 98 | VERA | Vera Therapeutics, Inc. | Healthcare | 0.09% | $84,110.04 | $2.01B | — |
| 99 | XERS | Xeris Biopharma Holdings, Inc. | Healthcare | 0.08% | $78,230.87 | $1.88B | — |
| 100 | ZA8 | ZYMEWORKS DL-00001 | Healthcare | 0.08% | $76,524.01 | — | — |
| 101 | RXRX | Recursion Pharmaceuticals, Inc. | Healthcare | 0.08% | $75,670.59 | $1.86B | — |
| 102 | BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | 0.08% | $75,386.11 | $1.99B | — |
| 103 | SEPN | Septerna, Inc. | Healthcare | 0.08% | $75,291.28 | $1.70B | — |
| 104 | MLYS | Mineralys Therapeutics, Inc. | Healthcare | 0.08% | $74,911.98 | $1.79B | — |
| 105 | XNCR | Xencor, Inc. | Healthcare | 0.07% | $70,644.84 | $1.70B | — |
| 106 | SRPT | Sarepta Therapeutics, Inc. | Healthcare | 0.07% | $70,644.84 | $1.81B | — |
| 107 | GPCR | Structure Therapeutics Inc. | Healthcare | 0.07% | $70,170.72 | $1.50B | — |
| 108 | MAZE | Maze Therapeutics, Inc. | Healthcare | 0.07% | $69,317.29 | $1.53B | — |
| 109 | VIR | Vir Biotechnology, Inc. | Healthcare | 0.07% | $68,937.99 | $1.69B | — |
| 110 | TRVI | Trevi Therapeutics, Inc. | Healthcare | 0.07% | $67,420.78 | $1.69B | — |
| 111 | ZBIO | Zenas BioPharma, Inc. | Healthcare | 0.07% | $67,325.96 | $1.62B | — |
| 112 | LEGN | Legend Biotech Corporation | Healthcare | 0.07% | $67,136.31 | $3.59B | — |
| 113 | URGN | UroGen Pharma Ltd. | Healthcare | 0.07% | $66,282.88 | $1.69B | — |
| 114 | NVCR | NovoCure Limited | Healthcare | 0.07% | $65,903.58 | $1.64B | — |
| 115 | ANIP | ANI Pharmaceuticals, Inc. | Healthcare | 0.07% | $65,808.75 | $1.66B | 15.6 |
| 116 | PSNL | Personalis, Inc. | Healthcare | 0.07% | $63,912.25 | $1.67B | — |
| 117 | ALVO | Alvotech | Healthcare | 0.07% | $62,015.74 | — | — |
| 118 | ABSI | Absci Corporation | Healthcare | 0.06% | $61,541.62 | $1.42B | — |
| 119 | STOK | Stoke Therapeutics, Inc. | Healthcare | 0.06% | $61,446.79 | $1.56B | — |
| 120 | QURE | uniQure N.V. | Healthcare | 0.06% | $61,351.97 | $1.51B | — |
| 121 | NVAX | Novavax, Inc. | Healthcare | 0.06% | $61,067.49 | $1.86B | — |
| 122 | RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | 0.06% | $60,593.36 | $1.43B | — |
| 123 | NTLA | Intellia Therapeutics, Inc. | Healthcare | 0.06% | $58,791.68 | $1.60B | — |
| 124 | CMPS | COMPASS Pathways plc | Healthcare | 0.06% | $58,507.21 | $1.49B | — |
| 125 | TRAX | First Tracks Biotherapeutics | Healthcare | 0.06% | $57,938.26 | $1.23B | — |
| 126 | PCRX | Pacira BioSciences, Inc. | Healthcare | 0.06% | $57,938.26 | $1.45B | 103.8 |
| 127 | INVA | Innoviva, Inc. | Healthcare | 0.06% | $57,464.13 | $1.50B | 4.9 |
| 128 | IMCR | Immunocore Holdings plc | Healthcare | 0.06% | $56,895.18 | $1.51B | — |
| 129 | OCUL | Ocular Therapeutix, Inc. | Healthcare | 0.06% | $53,196.99 | $1.51B | — |
| 130 | ETON | Eton Pharmaceuticals, Inc. | Healthcare | 0.06% | $52,343.56 | $1.44B | 125.8 |
| 131 | INBX | Inhibrx, Inc. | Healthcare | 0.06% | $52,343.56 | $1.32B | — |
| 132 | ORIC | ORIC Pharmaceuticals, Inc. | Healthcare | 0.06% | $52,343.56 | $1.28B | — |
| 133 | ANAB | AnaptysBio, Inc. | Healthcare | 0.06% | $52,153.91 | $1.39B | — |
| 134 | TSHA | Taysha Gene Therapies, Inc. | Healthcare | 0.05% | $51,016.01 | $1.18B | — |
| 135 | RAPP | Rapport Therapeutics, Inc. | Healthcare | 0.05% | $49,688.45 | $1.32B | — |
| 136 | GHRS | GH Research PLC | Healthcare | 0.05% | $49,593.63 | $1.25B | — |
| 137 | TYRA_old | TYRA | Healthcare | 0.05% | $48,645.38 | — | — |
| 138 | OMER | Omeros Corporation | Healthcare | 0.05% | $47,791.95 | $1.17B | 13.3 |
| 139 | SNDX | Syndax Pharmaceuticals, Inc. | Healthcare | 0.05% | $47,412.65 | $1.15B | — |
| 140 | AMPH | Amphastar Pharmaceuticals, Inc. | Healthcare | 0.05% | $44,378.24 | $1.10B | 15.3 |
| 141 | BCAX | Bicara Therapeutics Inc. | Healthcare | 0.05% | $44,283.41 | $1.11B | — |
| 142 | REPL | Replimune Group, Inc. | Healthcare | 0.04% | $42,671.38 | $1.02B | — |
| 143 | VOR | Vor Biopharma Inc. | Healthcare | 0.04% | $42,292.08 | $977.0M | 0.1 |
| 144 | MRVI | Maravai LifeSciences Holdings, Inc. | Healthcare | 0.04% | $42,197.26 | $2.51B | — |
| 145 | JANX | Janux Therapeutics, Inc. | Healthcare | 0.04% | $41,817.96 | $1.01B | — |
| 146 | HROW | Harrow Health, Inc. | Healthcare | 0.04% | $41,343.83 | $1.02B | — |
| 147 | MNKD | MannKind Corporation | Healthcare | 0.04% | $41,249.00 | $977.5M | — |
| 148 | CSTL | Castle Biosciences, Inc. | Healthcare | 0.04% | $39,352.50 | $976.4M | — |
| 149 | ZLAB | Zai Lab Limited | Healthcare | 0.04% | $38,688.72 | $2.60B | — |
| 150 | CGEM | Cullinan Oncology, Inc. | Healthcare | 0.04% | $38,309.42 | $794.7M | — |
| 151 | GLUE | Monte Rosa Therapeutics, Inc. | Healthcare | 0.04% | $36,602.56 | $831.0M | — |
| 152 | AVBP | ArriVent BioPharma, Inc. | Healthcare | 0.04% | $36,602.56 | $821.5M | — |
| 153 | MGTX | MeiraGTx Holdings plc | Healthcare | 0.04% | $36,223.26 | $891.3M | 10.7 |
| 154 | SVRA | Savara Inc. | Healthcare | 0.04% | $36,033.61 | $914.3M | — |
| 155 | CRVS | Corvus Pharmaceuticals, Inc. | Healthcare | 0.04% | $35,559.49 | $800.8M | — |
| 156 | ALMS | Alumis Inc. | Healthcare | 0.04% | $35,085.36 | $792.1M | — |
| 157 | SLN | Silence Therapeutics plc | Healthcare | 0.04% | $33,947.46 | $539.5M | — |
| 158 | KURA | Kura Oncology, Inc. | Healthcare | 0.04% | $33,757.81 | $807.8M | — |
| 159 | RIGL | Rigel Pharmaceuticals, Inc. | Healthcare | 0.04% | $33,568.15 | $858.7M | 2.7 |
| 160 | GRFS | Grifols, S.A. | Healthcare | 0.04% | $33,378.50 | $5.20B | 9.9 |
| 161 | PAHC | Phibro Animal Health Corporation | Healthcare | 0.03% | $32,999.20 | $1.58B | 16.0 |
| 162 | TKM | Arbutus Biopharma Corp | Other | 0.03% | $32,714.73 | — | — |
| 163 | ARDX | Ardelyx, Inc. | Healthcare | 0.03% | $31,956.12 | $797.8M | — |
| 164 | COLL | Collegium Pharmaceutical, Inc. | Healthcare | 0.03% | $29,680.32 | $755.0M | 18.3 |
| 165 | GERN | Geron Corporation | Healthcare | 0.03% | $28,826.89 | $751.7M | — |
| 166 | ANNX | Annexon, Inc. | Healthcare | 0.03% | $28,257.94 | $646.5M | — |
| 167 | SANA | Sana Biotechnology, Inc. | Healthcare | 0.03% | $28,163.11 | $679.5M | — |
| 168 | OABI | OmniAb, Inc. | Healthcare | 0.03% | $26,171.78 | $667.3M | — |
| 169 | PRME | Prime Medicine, Inc. | Healthcare | 0.03% | $25,697.65 | $629.4M | — |
| 170 | AURA | Aura Biosciences, Inc. | Healthcare | 0.03% | $25,413.18 | $632.6M | — |
| 171 | SLDB | Solid Biosciences Inc. | Healthcare | 0.03% | $25,223.53 | $593.0M | — |
| 172 | WVE | Wave Life Sciences Ltd. | Healthcare | 0.03% | $25,033.88 | $616.8M | — |
| 173 | MESO | Mesoblast Limited | Healthcare | 0.03% | $24,939.05 | $1.72B | — |
| 174 | DSGN | Design Therapeutics, Inc. | Healthcare | 0.03% | $24,844.23 | $645.2M | — |
| 175 | FDMT | 4D Molecular Therapeutics, Inc. | Healthcare | 0.03% | $24,844.23 | $670.7M | — |
| 176 | CADL | Candel Therapeutics, Inc. | Healthcare | 0.03% | $24,275.28 | $626.7M | — |
| 177 | PACB | Pacific Biosciences of California, Inc. | Healthcare | 0.03% | $24,275.28 | $537.7M | — |
| 178 | CRMD | CorMedix Inc. | Healthcare | 0.03% | $23,895.97 | $565.9M | 3.5 |
| 179 | OLMA | Olema Pharmaceuticals, Inc. | Healthcare | 0.02% | $23,232.20 | $575.7M | — |
| 180 | KMPH | KemPharm Inc | Healthcare | 0.02% | $23,137.37 | — | — |
| 181 | SGMT | Sagimet Biosciences Inc. | Healthcare | 0.02% | $23,137.37 | $568.7M | — |
| 182 | PHAT | Phathom Pharmaceuticals, Inc. | Healthcare | 0.02% | $22,473.59 | $559.8M | — |
| 183 | IRWD | Ironwood Pharmaceuticals, Inc. | Healthcare | 0.02% | $22,378.77 | $578.3M | 4.5 |
| 184 | ACRS | Aclaris Therapeutics, Inc. | Healthcare | 0.02% | $22,283.94 | $482.8M | — |
| 185 | PBYI | Puma Biotechnology, Inc. | Healthcare | 0.02% | $22,094.29 | $507.4M | 19.3 |
| 186 | CTMX | CytomX Therapeutics, Inc. | Healthcare | 0.02% | $20,197.79 | $496.8M | — |
| 187 | AQST | Aquestive Therapeutics, Inc. | Healthcare | 0.02% | $19,723.66 | $474.4M | — |
| 188 | ARVN | Arvinas, Inc. | Healthcare | 0.02% | $18,775.41 | $449.7M | 26.8 |
| 189 | RGNX | REGENXBIO Inc. | Healthcare | 0.02% | $18,680.58 | $457.1M | — |
| 190 | GLPG | Galapagos NV ADR | Healthcare | 0.02% | $18,396.11 | — | — |
| 191 | EOLS | Evolus, Inc. | Healthcare | 0.02% | $18,206.46 | $469.0M | — |
| 192 | NGNE | Neurogene Inc. | Healthcare | 0.02% | $18,016.81 | $465.3M | — |
| 193 | KMDA | Kamada | Healthcare | 0.02% | $16,499.60 | — | — |
| 194 | ALLO | Allogene Therapeutics, Inc. | Healthcare | 0.02% | $15,835.82 | $452.6M | — |
| 195 | SPRY | ARS Pharmaceuticals, Inc. | Healthcare | 0.02% | $15,741.00 | $399.8M | — |
| 196 | PRTA | Prothena Corporation plc | Healthcare | 0.02% | $15,456.52 | $428.7M | — |
| 197 | ALT | Altimmune, Inc. | Healthcare | 0.02% | $15,456.52 | $427.9M | — |
| 198 | CCCC | C4 Therapeutics, Inc. | Healthcare | 0.02% | $15,266.87 | $340.2M | — |
| 199 | TECX | Tectonic Therapeutic Inc. | Healthcare | 0.02% | $15,077.22 | $403.7M | — |
| 200 | EDIT | Editas Medicine, Inc. | Healthcare | 0.01% | $14,223.79 | $360.9M | — |
| 201 | KYTX | Kyverna Therapeutics, Inc. | Healthcare | 0.01% | $13,844.49 | $350.7M | — |
| 202 | ENTA | Enanta Pharmaceuticals, Inc. | Healthcare | 0.01% | $13,370.37 | $323.3M | — |
| 203 | OBIO | Orchestra BioMed Holdings, Inc. | Healthcare | 0.01% | $12,991.07 | $327.6M | — |
| 204 | TKNO | Alpha Teknova, Inc. | Healthcare | 0.01% | $12,896.24 | $380.1M | — |
| 205 | AVIR | Atea Pharmaceuticals, Inc. | Healthcare | 0.01% | $12,706.59 | $346.5M | — |
| 206 | AUTL | Autolus Therapeutics plc | Healthcare | 0.01% | $12,516.94 | $425.9M | — |
| 207 | ARCT | Arcturus Therapeutics Holdings Inc. | Healthcare | 0.01% | $11,947.99 | $293.9M | — |
| 208 | FULC | Fulcrum Therapeutics, Inc. | Healthcare | 0.01% | $10,904.91 | $278.8M | — |
| 209 | CTNM | Contineum Therapeutics, Inc. | Healthcare | 0.01% | $10,715.26 | $266.4M | — |
| 210 | CABA | Cabaletta Bio, Inc. | Healthcare | 0.01% | $10,241.13 | $239.1M | — |
| 211 | BIOA | BioAge Labs, Inc | Healthcare | 0.01% | $10,051.48 | $222.1M | — |
| 212 | RCKT | Rocket Pharmaceuticals, Inc. | Healthcare | 0.01% | $10,051.48 | $239.3M | — |
| 213 | ACIU | AC Immune SA | Healthcare | 0.01% | $9,861.83 | $237.6M | — |
| 214 | IMRX | Immuneering Corporation | Healthcare | 0.01% | $9,767.01 | $232.3M | — |
| 215 | VNDA | Vanda Pharmaceuticals Inc. | Healthcare | 0.01% | $9,767.01 | $243.7M | — |
| 216 | LNDC | Landec Corporation | Healthcare | 0.01% | $9,577.35 | — | — |
| 217 | LRMR | Larimar Therapeutics, Inc. | Healthcare | 0.01% | $9,387.70 | $206.2M | — |
| 218 | LXEO | Lexeo Therapeutics, Inc. | Healthcare | 0.01% | $9,103.23 | $216.7M | — |
| 219 | QSI | Quantum-Si incorporated | Healthcare | 0.01% | $9,103.23 | $245.1M | — |
| 220 | LYEL | Lyell Immunopharma, Inc. | Healthcare | 0.01% | $8,818.75 | $199.0M | — |
| 221 | SIGA | SIGA Technologies, Inc. | Healthcare | 0.01% | $8,723.93 | $227.8M | — |
| 222 | KROS | Keros Therapeutics, Inc. | Healthcare | 0.01% | $8,629.10 | $211.4M | — |
| 223 | PEPG | PepGen Inc. | Healthcare | 0.01% | $6,827.42 | $179.8M | — |
| 224 | ADGI | Adagio Therapeutics Inc | Healthcare | 0.01% | $6,827.42 | — | — |
| 225 | TRDA | Entrada Therapeutics, Inc. | Healthcare | 0.01% | $6,732.60 | $170.2M | — |
| 226 | SION | Sionna Therapeutics, Inc. | Healthcare | 0.01% | $6,637.77 | $175.6M | — |
| 227 | BCYC | Bicycle Therapeutics plc | Healthcare | 0.01% | $6,448.12 | $241.5M | — |
| 228 | CHRS | Coherus BioSciences, Inc. | Healthcare | 0.01% | $6,258.47 | $153.0M | — |
| 229 | UPB | Upstream Bio, Inc. | Healthcare | 0.01% | $6,163.64 | $151.2M | — |
| 230 | IMAB | I-Mab | Healthcare | 0.01% | $5,784.34 | — | — |
| 231 | CDXS | Codexis, Inc. | Healthcare | 0.01% | $5,594.69 | $135.8M | — |
| 232 | PYXS | Pyxis Oncology, Inc. | Healthcare | 0.01% | $5,499.87 | $200.7M | — |
| 233 | MENS | Jyong Biotech Ltd. | Healthcare | 0.01% | $5,120.57 | $139.9M | — |
| 234 | AVXL | Anavex Life Sciences Corp. | Healthcare | 0.00% | $4,646.44 | $121.4M | — |
| 235 | BDTX | Black Diamond Therapeutics, Inc. | Healthcare | 0.00% | $4,361.96 | $98.8M | — |
| 236 | FHTX | Foghorn Therapeutics Inc. | Healthcare | 0.00% | $4,361.96 | $109.9M | — |
| 237 | HUMA | Humacyte, Inc. | Healthcare | 0.00% | $4,172.31 | $119.2M | — |
| 238 | VYGR | Voyager Therapeutics, Inc. | Healthcare | 0.00% | $4,172.31 | $117.1M | — |
| 239 | LENZ | LENZ Therapeutics, Inc. | Healthcare | 0.00% | $3,698.19 | $102.7M | — |
| 240 | TNYA | Tenaya Therapeutics, Inc. | Healthcare | 0.00% | $3,413.71 | $85.4M | — |
| 241 | AARD | Aardvark Therapeutics, Inc. | Healthcare | 0.00% | $3,413.71 | $82.7M | — |
| 242 | NMRA | Neumora Therapeutics, Inc. | Healthcare | 0.00% | $3,034.41 | $89.0M | — |
| 243 | RANI | Rani Therapeutics Holdings, Inc. | Healthcare | 0.00% | $2,560.28 | $90.0M | — |
| 244 | CRBU | Caribou Biosciences, Inc. | Healthcare | 0.00% | $2,275.81 | $50.4M | — |
| 245 | EYPT | EyePoint Pharmaceuticals, Inc. | Healthcare | 0.00% | $1,422.38 | $250.7M | — |
Weights as a percentage of net assets. Value held = weight × net assets ($94.8M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
BIB sector breakdown
| Sector | Weight | Holdings | Largest |
|---|---|---|---|
| Healthcare | 60.8% | 240 | GILD, VRTX, AMGN |
| Other | 18.6% | 3 | IQMM, KH6_old, TKM |
| Financial Services | 0.2% | 1 | BCTG |
| Technology | 0.1% | 1 | AUP |
Sum of the weights of the holdings in each sector.
BIB top industries
Biotechnology
39.5%
Drug Manufacturers - General
12.0%
Drug Manufacturers - Specialty & Generic
4.3%
Diagnostics & Research
3.9%
Health Information Services
0.5%
Medical Devices
0.4%
Shell Companies
0.2%
Technical & System Software
0.1%
Medical Care Facilities
0.1%
Pharmaceuticals
0.0%
BIB overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| IBBQ | Invesco Nasdaq Biotechnology ETF | 61.2% | 244 of 245 | 0.18% |
| IBB | iShares Biotechnology ETF | 53.8% | 196 of 234 | 0.46% |
| BIS | ProShares UltraShort Nasdaq Biotechnology | 36.2% | 55 of 104 | 0.96% |
| IWM | iShares Russell 2000 ETF | 10.4% | 170 of 1,962 | 0.19% |
| DIA | SPDR Dow Jones Industrial Average ETF | 4.9% | 1 of 30 | 0.16% |
| QQQ | Invesco QQQ ETF | 3.3% | 6 of 101 | 0.17% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the BIB portfolio
ProShares Ultra Nasdaq Biotechnology holds 246 positions. The ten largest make up 46.2% of the fund and the top 50 67.5%, so it behaves like a portfolio of about 14 equally weighted stocks. The biggest positions are Proshares Genius Money Market ETF (18.43%), Gilead Sciences, Inc. (5.17%), Vertex Pharmaceuticals Incorporated (5.05%), Amgen Inc. (4.91%), Moderna, Inc. (3.35%).
By sector, Healthcare is 60.8%, Other is 18.6%, Financial Services is 0.2%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: BIB chart, BIB performance, BIB dividends, BIB overview.
BIB holdings FAQ
How many holdings does BIB have?
BIB holds 246 positions as of October 25, 2026.
What are the top 10 holdings of BIB?
The ten largest holdings are Proshares Genius Money Market ETF (18.43%), Gilead Sciences, Inc. (5.17%), Vertex Pharmaceuticals Incorporated (5.05%), Amgen Inc. (4.91%), Moderna, Inc. (3.35%), Regeneron Pharmaceuticals, Inc. (3.25%), Revolution Medicines, Inc. (1.64%), Illumina, Inc. (1.62%), Biogen Inc. (1.55%), Alnylam Pharmaceuticals, Inc. (1.22%). Together they are 46.2% of the fund.
What percentage of BIB is Proshares Genius Money Market ETF?
Proshares Genius Money Market ETF is the largest holding at 18.43% of net assets, about $17.5M of the fund's $94.8M.
Which sector is the largest in BIB?
Healthcare is the largest sector at 60.8%, followed by Other (18.6%) and Financial Services (0.2%), based on the sectors of the individual holdings.
How concentrated is BIB?
The top 10 holdings are 46.2% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) BIB behaves like a portfolio of about 14 equally weighted stocks.